Rare and common diseases should be treated equally and why the article by de Magalhaes somewhat misses its’ mark

Journal of Medical Ethics 48 (2):97-98 (2022)
  Copy   BIBTEX

Abstract

In the article Should rare diseases get special treatment? by Monica Q F de Magalhaes,1 it is argued that rarity is not a morally relevant feature to consider in prioritising treatment in healthcare, but severity is. A central conclusion in the article is that severity rather than prevalence should guide different cost-effectiveness thresholds. Hence, I take it, she answers no to the question in her own heading. I agree with all of this—and with most of her other arguments and conclusions in the article—except for the clause ‘rather than prevalence’. For this reason, I find the article misses its’ mark. Let me explain by taking Sweden as an example. Sweden has a legally established ethics framework for priority setting in healthcare since 1997, comprising three principles: human-dignity principle, needs-solidarity principle and cost-effectiveness principle. The implication of these principles in practice is that the higher the severity—the higher the cost-effectiveness threshold acceptable.2 During the last 10 years or so, the highest accepted cost-effectiveness threshold for the most severe conditions have been in the order of €100 000/QALY. Until a few years ago rarity or prevalence was …

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 90,593

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Should rare diseases get special treatment?Monica Magalhaes - 2022 - Journal of Medical Ethics 48 (2):86-92.
Child Bereavement and Rare Diseases.Solange do Carmo Bowoniuk Wiegand & Caroline Filla Rosaneli - 2019 - Revista Iberoamericana de Bioética 10 (10):1-11.
Orphan Tests.Leslie G. Biesecker - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (2):300.
Double bad luck: Should rare diseases get special treatment?Adam Hutchings - 2022 - Journal of Medical Ethics 48 (2):99-100.
Aktualne problemy medycyny – technika czy etyka?Wojciech Płazak - 2018 - Philosophical Problems in Science 65:177-193.
Challenges of economic evaluation in rare diseases.Stephen Duckett - 2022 - Journal of Medical Ethics 48 (2):93-94.
Recognition memory for common and rare words.P. D. McCormack & Amy L. Swenson - 1972 - Journal of Experimental Psychology 95 (1):72.

Analytics

Added to PP
2022-01-21

Downloads
17 (#742,076)

6 months
5 (#246,492)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Should rare diseases get special treatment?Monica Magalhaes - 2022 - Journal of Medical Ethics 48 (2):86-92.

Add more references